Variant report
Variant | nsv553829 |
---|---|
Chromosome Location | chr11:25041755-25082823 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:22849480..22851377-chr11:25062549..25065391,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000198168 | chromatin interactions |
ENSG00000246225 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7929174 | chr11:25044605-25044606 | Bivalent/Poised TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs558969544 | chr11:25044650-25044651 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576034146 | chr11:25044665-25044666 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs143172453 | chr11:25044667-25044668 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs555242743 | chr11:25044673-25044674 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575093140 | chr11:25044703-25044704 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540319119 | chr11:25044724-25044725 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138535638 | chr11:25044741-25044742 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs141486646 | chr11:25044754-25044755 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs546214716 | chr11:25044758-25044759 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562423276 | chr11:25044772-25044773 | Bivalent/Poised TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1584196 | chr11:25058619-25058620 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs188670776 | chr11:25058636-25058637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1584197 | chr11:25058660-25058661 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs192583726 | chr11:25058688-25058689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs567077188 | chr11:25058705-25058706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs80021051 | chr11:25058709-25058710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139421364 | chr11:25058711-25058712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575570756 | chr11:25058741-25058742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575308515 | chr11:25058804-25058805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182800724 | chr11:25058807-25058808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145144073 | chr11:25058808-25058809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs574347055 | chr11:25058820-25058821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147576935 | chr11:25058876-25058877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79995178 | chr11:25058881-25058882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12789313 | chr11:25058937-25058938 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs10834586 | chr11:25058954-25058955 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs562479922 | chr11:25058961-25058962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557219437 | chr11:25058968-25058969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142586149 | chr11:25058984-25058985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12788430 | chr11:25058989-25058990 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs59899970 | chr11:25059073-25059074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs530376427 | chr11:25059131-25059132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146743477 | chr11:25059149-25059150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs186707707 | chr11:25059152-25059153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151334444 | chr11:25059224-25059225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114730561 | chr11:25059303-25059304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532621032 | chr11:25059318-25059319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552622110 | chr11:25059325-25059326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564823296 | chr11:25059364-25059365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs11028373 | chr11:25059404-25059405 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs369875515 | chr11:25059429-25059430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554504863 | chr11:25059437-25059438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372392964 | chr11:25059447-25059448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75046618 | chr11:25059482-25059483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554314916 | chr11:25059488-25059489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs75751815 | chr11:25059566-25059567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs895409 | chr11:25059567-25059568 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs554626546 | chr11:25059568-25059569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191610265 | chr11:25059579-25059580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25044600-25044800 | Bivalent/Poised TSS | ES-WA7 Cell Line | embryonic stem cell |
2 | chr11:25058600-25060800 | Enhancers | Fetal Heart | heart |
3 | chr11:25068600-25069400 | Enhancers | Brain Germinal Matrix | brain |
4 | chr11:25069400-25069600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr11:25069400-25070000 | Enhancers | Fetal Heart | heart |
6 | chr11:25069600-25070000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr11:25069600-25070600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr11:25069800-25071600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr11:25070000-25070400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
10 | chr11:25070000-25072200 | Weak transcription | Fetal Heart | heart |
11 | chr11:25070400-25071000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
12 | chr11:25070600-25071000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr11:25070600-25071000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr11:25070600-25071200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr11:25070600-25071800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr11:25072200-25074000 | Enhancers | Fetal Heart | heart |
17 | chr11:25079000-25079400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |